ESG

Karma Automotive will use Factorial's advanced solid-state batteries in its Kaveya supercar, sparking a new chapter for American EV manufacturing and innovation.

A new initiative unites top scientists to study 'SuperAgers' and resilient brains, aiming to unlock the secrets of healthy aging and prevent Alzheimer's.

A new report reveals a looming crisis: rising healthcare costs will consume more than 100% of Social Security benefits for future generations of retirees.

A new survey reveals 84% of firms doubt they can pass an AI compliance audit, exposing a massive security gap as autonomous agent adoption surges.

A landmark deal sees US tech giant CrowdStrike partner with Aramco to build a national cybersecurity defense, securing Saudi Arabia's AI-driven future.

With backing from top VCs, Angitia Biopharmaceuticals is accelerating its novel treatments for osteoporosis and rare bone disorders. Here's why it matters.

Despite product withdrawals, a lack of regulation and the long latency of asbestos-related diseases mean the danger from talc exposure is far from over.

Pluristyx and Solesis launch a 'three-in-one' kit with nearly 100% efficiency in iPSC transfection, tackling a major bottleneck in organoid research.

For its tenth straight Games, Technogym will equip Milano Cortina 2026 with AI-driven gear, cementing its legacy as the force behind athletic excellence.

A new study reveals Exicure's burixafor mobilizes stem cells in one hour, promising to streamline cancer treatment and unlock future gene therapies.

New data reveals an AI-powered system can map and guide heart arrhythmia treatment in minutes with zero fluoroscopy, heralding a new era of safety and speed.

With major drug approvals on the horizon, Nuvalent's leadership will detail its strategy for its next-gen cancer therapies at an influential investor summit.

VectorY Therapeutics adds seasoned biotech architect Kevin Pojasek to its board, signaling a strategic push to accelerate its novel therapies for ALS and Alzheimer's.

As it enters its tenth year, the Zephyr RTOS adds Schneider Electric and others, signaling a major push for standardization and security in a regulated IoT world.

A new report reveals how GLP-1 drugs are accelerating a major healthcare shift in the Gulf, turning metabolic health into a core economic and policy issue.

After years of losses, the electric vehicle maker projects its first-ever adjusted quarterly profit, signaling a new era of financial discipline.

After conquering the US, the AI finance app is back on home turf. But can its playful 'roast mode' succeed in a crowded British FinTech market?

Positive study results for Alvotech's Entyvio biosimilar could disrupt the IBD market, promising lower costs for a blockbuster chronic care treatment.

Bahrain's hospitality giant leverages five decades of experience to challenge the institutional catering sector with a new, tech-driven, large-scale operation.

Kenmare Resources unveils its upgraded Moma Mine, a critical global titanium source, as it pivots from heavy spending to cash generation.